DS
CBAY

David Shaw’s Cymabay Therapeutics CBAY Stock Holding History

David Shaw’s Portfolio CBAY Stock Details CBAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-150,000
Closed -$3.54M – 4859
2023
Q4 		$3.54M Buy
+150,000
New +$2.67M ﹤0.01% 2200

Other funds holding CBAY

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

David Shaw's CBAY Position: Q1 2024 in Review

David Shaw sold out of Cymabay Therapeutics (CBAY) in Q1 2024, closing a stake of 636,897 shares — an estimated $15M sold.

David Shaw first reported a position in CBAY in Q4 2018 and held it in 21 quarters. The position peaked at $15M in Q4 2023. 1 fund tracked by Wall St. Rank holds CBAY as of Q1 2024.

  • David Shaw reported no remaining Cymabay Therapeutics position as of Q1 2024 after selling out during the quarter.
  • David Shaw sold 636,897 Cymabay Therapeutics shares in Q1 2024, an estimated $15M.
  • David Shaw first reported a position in Cymabay Therapeutics in Q4 2018 and held it in 21 quarters.
  • David Shaw's Cymabay Therapeutics position peaked at $15M in Q4 2023.
  • 1 fund tracked by Wall St. Rank held Cymabay Therapeutics as of Q1 2024.

Based on D.E. Shaw & Co's 13F filing for Q1 2024, filed 15 May 2024.